Globus Medical, Inc. (NYSE: GMED) has unveiled two groundbreaking additions to its anterior lumbar interbody fusion (ALIF) ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus ALIF blades. The Cohere space is the first porous ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

OsteoCentric Technologies has entered into a non-exclusive licensing agreement with Globus Medical.  OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...

OsteoCentric Technologies, a global leader in innovative medical technologies, announced it has entered into a non-exclusive ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Net income rose by 77% to $26.5 million, highlighting significant growth. Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full ...